Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

Seeking Alpha / 2 hours from now 1 Views

- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated:

Read more

Comments